We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.27B
AUM Growth
+$10.6M
(+0.84%)
Cap. Flow
+$22.3M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
51.69%
Holding
39
New
6
Increased
9
Reduced
11
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$70.5M |
| 2 |
Humana
HUM
|
+$68.8M |
| 3 |
HCA Healthcare
HCA
|
+$47.3M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$30M |
| 5 |
LKQ Corp
LKQ
|
+$25.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ironwood Pharmaceuticals
IRWD
|
+$56.6M |
| 2 |
Labcorp
LH
|
+$50.6M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$44.8M |
| 4 |
Viasat
VSAT
|
+$37.2M |
| 5 |
STAAR Surgical
STAA
|
+$17.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.59% |
| 2 | Consumer Discretionary | 13.16% |
| 3 | Technology | 12.9% |
| 4 | Communication Services | 7.05% |
| 5 | Consumer Staples | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
DexCom
DXCM
$32B
| $17.2M | 1.35% |
459,428
+254,220
| +124% | +$7.99M |
|
27
Wave Life Sciences
WVE
$1.09B
| $17M | 1.34% |
653,141
+256,051
| +64% | +$7.18M |
|
|
PVG
28
DELISTED
PRETIUM RESOURCES INC.
PVG
| $16.5M | 1.3% |
1,651,328
| – | – |
|
29
Teva Pharmaceuticals
TEVA
$40.9B
| $13.8M | 1.09% |
1,500,000
| – | – |
|
30
Cyclerion Therapeutics
CYCN
$15.1M
| $11.8M | 0.93% |
+51,632
| New | +$14.6M |
|
|
GDEN
31
DELISTED
Golden Entertainment
GDEN
| $11.5M | 0.9% |
822,487
| – | – |
|
32
Enphase Energy
ENPH
$4.98B
| – | – |
-724,723
| Closed | -$6.69M |
|
|
33
Ironwood Pharmaceuticals
IRWD
$688M
| – | – |
-4,993,179
| Closed | -$56.6M |
|
|
34
Labcorp
LH
$25.5B
| – | – |
-385,364
| Closed | -$50.6M |
|
|
35
STAAR Surgical
STAA
$1.21B
| – | – |
-514,105
| Closed | -$17.6M |
|
|
36
Viasat
VSAT
$10.6B
| – | – |
-480,179
| Closed | -$37.2M |
|
|
NVRO
37
DELISTED
NEVRO CORP.
NVRO
| – | – |
-183,141
| Closed | -$11.4M |
|
|
WMGI
38
DELISTED
Wright Medical Group Inc
WMGI
| – | – |
-1,424,239
| Closed | -$44.8M |
|
|
CZR
39
DELISTED
Caesars Entertainment Corporation
CZR
| – | – |
-1,377,004
| Closed | -$12M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q2 2019 Portfolio in Review
As of Q2 2019, Bridger Management held 39 positions worth $1.27B, up 0.84% from $1.26B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Bridger Management's Q2 2019 filing shows 6 new, 9 increased, 11 reduced and 8 closed positions. Its largest new stake was Alcon: 1,200,916 shares worth $74.5M. The largest sale was Ironwood Pharmaceuticals, an estimated $56.6M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Consumer Discretionary and Technology.
- Bridger Management's largest Q2 2019 buy was Alcon: 1,200,916 shares worth $74.5M.
- Bridger Management added most to Caesars Entertainment in Q2 2019, an estimated $19.9M increase.
- Bridger Management's biggest Q2 2019 reduction was Medicines Co, cutting an estimated $17.2M.
- Bridger Management fully exited Ironwood Pharmaceuticals in Q2 2019, selling an estimated $56.6M.
- Bridger Management's ten largest holdings make up 52% of its $1.27B portfolio in Q2 2019.
- Bridger Management opened 6 new positions and closed 8 in Q2 2019.
- Bridger Management's portfolio value rose 0.84% quarter-over-quarter to $1.27B.
Based on Bridger Management's 13F filing for Q2 2019, filed 14 Aug 2019.